Gastroenterology
News
Drugs
Xagena Medicine
Xagena.net
FGF15 controls the production of bile acid
Visceral pain, Oxycodone seems to be more effective than Morphine
Enhancing innate immunity improves Crohn's disease symptoms
Crohn’s disease, Tysabri Phase III trial meets primary endpoint
Ulcerative colitis, MLN02 induces remission
Crohn’s, GM-CSF decreases severity and improves quality of life
UDCA may reduce recurrence of high-grade colorectal adenomas
Infliximab shows efficacy in treatment of ulcerative colitis
Zelnorm shows promise in the treatment of upper gastrointestinal disorders
Timing of gluten exposure linked to celiac disease
Rifaximin as a potential treatment option for Crohn's disease
Rifaximin for prevention of traveler's diarrhea
GERD linked to sleep disturbance
New surgical options for obese patients
Biological therapies for inflammatory bowel diseases
Crohn’s disease, efficacy of the treatment with Adalimumab
Esomeprazole may reduce upper GI symptoms in patients using NSAIDs
Mediterranean diet increases survival among elderly
Next Pages
1
[
2
]
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions